| Literature DB >> 33061397 |
Yasin Awol Wabe1, Dawit Yihdego Reda2, Estifanos Tsige Abreham3, Degeuf Beyene Gobene3, Musa Mohammed Ali2.
Abstract
INTRODUCTION: Asymptomatic bacteriuria (ASB) is the presence of bacteria in significant quantity in the absence of signs and symptoms of urinary tract infection (UTI). ASB, if it occurs during pregnancy, can cause serious complications both among fetus and pregnant women.Entities:
Keywords: Addis Ababa; Ethiopia; antibiotic susceptibility; asymptomatic bacteriuria; pregnant woman
Year: 2020 PMID: 33061397 PMCID: PMC7532909 DOI: 10.2147/TCRM.S267101
Source DB: PubMed Journal: Ther Clin Risk Manag ISSN: 1176-6336 Impact factor: 2.423
Socio-Demographic Characteristics of Pregnant Women Attending the Antenatal Clinic of the Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia, 2019 (N= 290)
| Variables | Category | Frequency | Percent |
|---|---|---|---|
| Age in years | 18–25 | 101 | 34.8 |
| 26–34 | 169 | 58.3 | |
| 35–43 | 20 | 6.9 | |
| Occupation | Housewife | 193 | 66.6 |
| Merchant | 55 | 19.0 | |
| Government employed | 38 | 13.0 | |
| Student | 4 | 1.4 | |
| Marital status | Married | 280 | 96.6 |
| Single | 10 | 3.4 | |
| Education | No formal education | 26 | 3.4 |
| Primary school | 125 | 43.1 | |
| Secondary school | 81 | 27.9 | |
| College or University level education | 58 | 20.0 | |
| Residence | Urban | 249 | 85.9 |
| Rural | 41 | 14.1 |
ASB Across Different Socio-Demographic Characteristics Among Pregnant Women Attending Antenatal Clinic of the Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia, 2019 (N=290)
| Variables | Tested | ASB | COR (95% CI) | |||
|---|---|---|---|---|---|---|
| Positive | Negative | |||||
| 18–25 | 101(34.8) | 17(16.8) | 84(83.2) | 1 | ||
| 26–34 | 169(58.3) | 30(17.8) | 139(82.2) | 1.06 (0.55, 2.05) | 0.847 | |
| 35–43 | 20(6.9) | 2(10.0) | 18(90.0) | 0.54 (0.12, 2.58) | 0.449 | |
| Housewife | 193(66.6) | 35(18.1) | 158(81.9) | 0.66 (0.07, 6.58) | 0.727 | |
| Merchant | 55(19.0) | 8(14.5) | 47(85.5) | 0.51 (0.05, 5.54) | 0.581 | |
| Government Employed | 38(13.0) | 5(13.2) | 33(86.8) | 0.45 (0.04, 5.27) | 0.528 | |
| Student | 4(1.4) | 1(25.0) | 3(75.0) | 1 | ||
| Married | 280(96.6) | 48(17.1) | 232(82.9) | 1.86 (0.23, 15.04) | 0.560 | |
| Single | 10(3.4) | 1(10.0) | 9(90.0) | 1 | ||
| No formal education | 26(9.0) | 6(23.1) | 20(76.9) | 3.18(0.87, 11.59) | 0.08 | |
| Primary school | 125(43.1) | 23(18.4) | 102(81.6) | 2.39(0.86, 6.64) | 0.95 | |
| Secondary school | 81(27.9) | 15(18.5) | 66(81.5) | 2.41(0.82, 7.05) | 0.11 | |
| Urban | 249(85.9) | 44(17.7) | 205(82.4) | 1 | ||
| Rural | 41(14.1) | 5(12.2) | 36(87.8) | 0.65(0.240–1.742) | 0.389 | |
| 1st Trimester | 51(17.6) | 8(15.7) | 43(84.3%) | 1 | ||
| 2nd Trimester | 66(22.8) | 10(15.2) | 56(84.8) | 0.96(0.349, 2.638) | 0.937 | |
| 3rd Trimester | 173(59.6) | 31(17.9) | 142(82.1) | 1.173(0.502, 2.742) | 0.712 | |
| Nulliparous | 86(29.7) | 17(19.8) | 69(80.2) | 1 | ||
| Primiparous | 109(37.6) | 16(14.7) | 93(85.3) | 0.69(0.33, 1.47) | 0.348 | |
| Multiparous | 95(32.8) | 16(16.8) | 79(83.2) | 0.82(0.38, 1.74) | 0.611 | |
| Yes | 14(4.5) | 3(21.4) | 11(78.6) | 1.36(0.17, 2.50) | 0.545 | |
| No | 276(95.5) | 46(16.7) | 230(83.3) | 1 | ||
| Yes | 14(4.8) | 1 (7.1) | 13(92.9) | 0.36(0.35, 21.42) | 0.338 | |
| No | 276(95.2) | 48(17.4) | 228(82.6) | 1 | ||
| Yes | 21(7.2) | 5(23.8) | 16(76.2) | 1.59(0.22, 1.79) | 0.384 | |
| No | 269(92.8) | 44(16.4) | 225(83.6) | 1 | ||
| Positive | 9(3.1) | 2(22.2) | 7(77.8) | 1.42(0.14,1.39) | 0.666 | |
| Negative | 281(96.6) | 47(16.7) | 234(83.3) | 1 | ||
Abbreviations: COR, crude odds ratio; CI, confidence interval; ASB, asymptomatic bacteriuria.
Bivariate and Multivariable Analyses of Factors Associated with ASB Among Pregnant Women Attending the Antenatal Clinic of the Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia, 2019 (N=290)
| Variables | Tested n(%) | ASB | Bivariate Analysis | Multivariate Analysis | ||||
|---|---|---|---|---|---|---|---|---|
| Positive n(%) | Negative n(%) | COR (95% CI) | P-value | AOR (95% CI) | ||||
| Yes | 91(31.4) | 28(30.8) | 63(69.2) | 3.76(1.99, 7.12) | 0.001 | 3.11(1.42, 6.79) | 0.004 | |
| No | 199(68.6) | 21(10.6) | 178(89.4) | 1 | ||||
| <11g/dl (Anemic) | 33(11.4) | 18(54.5) | 15(45.5) | 8.75(4.01,19.11) | 0.0001 | 10.49(4.58, 24.04) | 0.0001 | |
| ≥11g/dl (Normal) | 257(88.6) | 31(12.0) | 226(88.0) | 1 | ||||
| Yes | 89(30.7) | 23(25.8) | 66(74.2) | 2.34(1.25, 4.39) | 0.008 | 2.31(1.04, 5.13) | 0.04 | |
| No | 201(69.3) | 26(12.9) | 175(87.1) | 1 | ||||
| No formal education | 26(9) | 6(23.1) | 20(76.9) | 3.18(0.87, 11.59) | 0.08 | 3.26(0.72–14.83) | 0.126 | |
| Primary school | 125(43.1) | 23(18.4) | 102(81.6) | 2.39(0.86, 6.64) | 0.95 | 2.04(0.63, 6.62) | 0.233 | |
| Secondary school | 81(27.9) | 15(18.5) | 66(81.5) | 2.14(0.82, 7.05) | 0.11 | 2.45(0.72, 8.38) | 0.152 | |
| Higher education | 58(20.0) | 5(8.6) | 53(91.4) | 1 | ||||
| ≤500 | 20(6.9) | 3(15.0) | 17(85.0) | 0.98(0.26, 3.68) | 0.986 | 0.36(0.06, 1.92) | 0.232 | |
| 501–1000 | 58(20.0) | 13(22.4) | 45(77.6) | 1.62(0.74, 3.52) | 0.226 | 1.17(0.46, 2.95) | 0.735 | |
| 1001–1500 | 29(10.0) | 3(10.3) | 26(89.7) | 0.64(0.18, 2.34) | 0.506 | 0.54(0.13, 2.19) | 0.390 | |
| 1501–2000 | 51(17.6) | 10(19.6) | 41(80.4) | 1.36(0.59, 3.16) | 0.466 | 0.75(0.26, 2.12) | 0.590 | |
| >2000 | 132(45.5) | 20(15.2) | 112(84.8) | 1 | ||||
| Yes | 91(31.4) | 24(26.4) | 67(73.6) | 2.49(1.33, 4.66) | 0.004 | 2.36(1.13, 4.96) | 0.023 | |
| No | 199(68.6) | 25(12.6) | 174(87.4) | 1 | ||||
Abbreviations: COR, crude odds ratio; AOR, adjusted odds ratio; CI, confidence interval; ASB, asymptomatic bacteriuria.
Antimicrobial Susceptibility Profile of Gram-Negative Bacteria Isolated from Pregnant Women with ASB at Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia, 2019 (n=29)
| Type of Isolates (n) | Antimicrobial Agents | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GEN | CIP | AMP | AMX | AMC | TET | NIT | CEF | CRX | MER | COT | ||
| S | 20(91.0) | 18(81.8) | 10(45.5) | 1(4.5) | 10(45.5) | 15(68.2) | 20(91.0) | 18(81.8) | 18(81.8) | 18(81.8) | 6(27.3) | |
| I | 1(4.5) | 1(4.5) | – | 2(9.1) | 2(9.0) | – | – | – | 1(4.5) | 3(13.7) | – | |
| R | 1(4.5) | 3(13.7) | 12(54.5) | 19(86.4) | 10(45.5) | 7(31.8) | 2(9.0) | 4(18.02) | 3(13.7) | 1(4.5) | 16(77.7) | |
| S | 1(33.3) | 1(33.3) | 2(66.7) | 1(33.3) | 2(66.7) | 1(33.3) | 3(100) | 1(33.3) | 2(66.7) | 1(33.3) | 1(33.3) | |
| I | 1(33.3) | – | – | – | – | 1(33.3) | – | 1(33.3) | – | – | – | |
| R | 1(33.4) | 2(66.7) | 1(33.3) | 2(66.7) | 1(33.3) | 1(33.3) | – | 1(33.3) | 1(33.3) | 2(66.7) | 2(66.7) | |
| S | 2(100) | – | 2(0.0) | 2(0.0) | 2(100) | 1(50.0) | 2(100) | 2(100) | 2(100) | 2(100) | – | |
| I | – | – | – | – | – | 1(50.0) | – | – | – | – | 2(100) | |
| R | – | 2(100) | – | – | – | – | – | – | – | – | – | |
| S | 1(0.0) | 1(100) | – | 1(100) | 1(100) | 1(100) | 1(100) | 1(100) | – | – | ||
| R | – | – | 1(100) | 1(100) | – | – | 1(100) | 1(100) | ||||
| S | 1(100) | 1(100) | – | – | 1(100) | 1(100) | 1(100) | 1(100) | 1(100) | 1(100) | 1(100) | |
| R | – | – | 1(100) | 1(100) | – | – | – | – | – | – | – | |
| Total (29) | S | 25(86.2) | 21(72.4) | 14(48.3) | 4(13.8) | 16(55.2) | 19(65.5) | 27(93.1) | 23(82.8) | 24(82.8) | 22(75.9) | 8(27.6) |
| I | 2(6.9) | 1(3.4) | – | 2(6.9) | 2(6.9) | 2(6.9) | 1(3.4) | 1(3.4) | 3(10.3) | 2(6.9 | ||
| R | 2(6.9) | 7(24.2) | 15(51.7) | 23(79.3) | 11(37.9) | 8(27.6) | 2(6.9) | 5(17.3) | 4(13.8) | 4(13.8) | 19(65.5) | |
Abbreviations: GEN, gentamycin; CIP, ciprofloxacin; AMP, ampicillin; AMX, amoxicillin; AMC, amoxicillin clavulanic acid; TET, tetracycline; NIT, nitrofurantoin; CEF, ceftriaxone; CRX, cefuroxime; MER, meropenem; COT, co-trimoxazole; S, susceptible; I, intermediate; R, resistance; ASB, asymptomatic bacteriuria.
Antimicrobial Susceptibility Profile of Gram-Positive Bacteria Isolated from Pregnant Women with ASB at Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia, 2019 (n=20)
| Type of Isolates (n) | Antimicrobial Agents n (%) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GEN | ERY | CIP | PEN | COT | TET | NIT | CD | AZT | AMP | ||
| S | 9(90.0) | 6(60.0) | 9(90.0) | 3(30.0) | 7(70.0) | 7(70.0) | 10(100) | 8(80.0) | 9(90.0) | NA | |
| I | 1(10.0) | 1(10.0) | 1(10.0) | – | – | – | – | 1(10.0) | – | NA | |
| R | – | 3(30.0) | – | 7(70.0) | 3(30.0) | 3(30.0) | – | 1(10.0) | 1(10.0) | NA | |
| S | 6(75.0) | 4(50.0) | 6(75.0) | 2(25.0) | 4(50.0) | 4(50.0) | 8(100) | 6(75.0) | 7(87.5) | NA | |
| I | 1(25.0) | 2(25.0) | 1(12.5) | – | 1(12.5) | 2(25.0) | – | 1(12.5) | 1(12.5) | NA | |
| R | 1(25.0) | 2(25.0) | 1(12.5) | 6(75.0) | 3(37.5) | 2(25.0) | – | 1(12.5) | – | NA | |
| S | 2(100) | NA | 2(100) | 1(50.0) | 1(50.0) | 1(50.0) | 2(100) | 2(100) | 2(100) | 1(50.0) | |
| I | – | NA | – | – | – | 1(50.0) | – | – | – | – | |
| R | – | NA | – | 1(50.0) | 1(50.0) | – | – | – | – | 1(50.0) | |
| Total (20) | S | 17(85.0 | 10(55.6) | 17(85.0) | 6(30.0) | 12(60.0) | 12(60.0) | 20(100) | 16(80.0) | 18(90.0 | 1(50.0) |
| I | 2(10.0) | 3(16.7) | 2(10.0) | – | 1(5.0) | 3(15.0) | – | 2(10.0) | 1(5.0) | – | |
| R | 1(5.0) | 5(27.7) | 1(5.0) | 14(70.0) | 7(35.0) | 5(25.0) | – | 2(10.0) | 1(5.0) | 1(50.0) | |
Abbreviations: GEN, gentamycin, ERY, erythromycin; CIP, ciprofloxacin; PEN, penicillin; COT, co-trimoxazole; TET, tetracycline; NIT, nitrofurantoin; CD, clindamycin; AZT, azithromycin; AMP, ampicillin; S, susceptible; I, intermediate; R, resistant; NA, not applicable; ASB, asymptomatic bacteriuria.
Multi-Drug Resistance Profile of Bacteria Isolated from Pregnant Women with ASB at Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia, 2019 (n=28)
| Bacterial Isolates | Combination of Antibiotics | N (%) |
|---|---|---|
| AMX, COT | 1 (8.3) | |
| AMX, MER | 1 (8.3) | |
| AMX, AMP, AMC, COT | 3 (25.0) | |
| AMX, AMP,AMC,TET,COT | 3 (25.0) | |
| AMX,AMP,AMC,CRT,CRX,COT | 1 (8.3) | |
| AMX,AMP,AMC,NIT,TET,COT | 1 (8.3) | |
| AMX,AMP,AMC, CTR,CRX,CRP,TET,COT | 2 (16.7) | |
| AMX, CRP,MER,COT | 1 (50.0) | |
| AMX,AMP,AMC,CTR,CRX,GEN,CRP,TET,MER,COT | 1 (50.0) | |
| AMX,AMP,COT | 1 (100) | |
| Total (Gram-negative) | 15(51.7) | |
| ERY,PEN | 3(42.9) | |
| TET,PEN | 1(14.2) | |
| COT,PEN | 1(14.2) | |
| PEN,TET,CD,COT | 1(14.2) | |
| PEN,TET,AZT,COT | 1(14.2) | |
| PEN,CD | 1(20.0) | |
| ERY,PEN | 1(20.0) | |
| COT,ERY | 1(20.0) | |
| GEN,PEN,TET,COT | 2(40.0) | |
| PEN, COT | 1(100) | |
| Total (Gram-positive) | 13(65) | |
| Overall total | 28(57.1) |
Abbreviations: AMX, amoxicillin; COT, co-trimoxazole; CIP, ciprofloxacin; AMP, ampicillin; AMC, amoxicillin-clavulanic acid; TET, tetracycline; GEN, gentamycin; NIT, nitrofurantoin; CTR, ceftriaxone; CRX, cefuroxime; MER, meropenem; ERY, erythromycin; PEN, penicillin; CD, clindamycin; AZT, azithromycin; ASB, asymptomatic bacteriuria.